Implantable Long-Acting Pre-Exposure Prophylaxis for HIV Prevention with MSM: A Qualitative Study of Patient and Physician Perspectives

Grants and Contracts Details

StatusActive
Effective start/end date11/21/2311/20/25

Funding

  • Merck Sharp & Dohme Corporation: $401,080.00